•
HKEX’s Latest Consultation Conclusions Will Enhance Its Listing Framework with Greater Flexibility and Stronger Competitiveness
HKEX has published the Consultation Conclusions (’Conclusions’) on its Competitiveness Review of the Listing Framework, confirming a series of Listing Rule amendments aimed at making Hong Kong a more attractive venue for companies seeking to raise capital while maintaining investor protection and market quality. The reforms represent the first phase of HKEX’s broader competitiveness review and have taken effect on 24 July 2026 after the publication of the Conclusions.
Why does this matter?
The reforms are intended to give a broader range of companies access to Hong Kong’s capital markets by refining listing eligibility requirements, expanding filing options and streamlining aspects of the listing process, while preserving the Exchange’s regulatory standards. According to HKEX, the proposals received broad market support during the consultation.
Katherine Ng, HKEX’s Head of Listing, explained that the reforms are designed to make Hong Kong’s listing regime more flexible and capable of accommodating a wider variety of companies. She indicated that the changes reinforce Hong Kong’s position as an international fundraising center by improving the competitiveness of its listing framework while continuing to uphold market quality and investor confidence.
Key listing rule changes
Area | Core change |
|---|---|
Weighted Voting Rights (WVR) | Reduced the minimum financial eligibility thresholds (see below ‘Financial eligibility thresholds’) for companies seeking to list with a WVR structure, including lower market capitalisation requirements for both the higher-threshold and revenue-based pathways. |
Weighted voting ratio increased from ≤ 10:1 to 20:1 if market capitalization at listing is ≥ HK$40 billion.
WVR shareholding percentage lowered from ≥ 10% to ≥ 5% for listings ≥ HK$4 billion. |
| Innovative Company Requirements | Introduced a revised approach for assessing whether applicants qualify as innovative companies, including new presumptions for certain commercialised Biotech Companies and Specialist Technology Companies, together with updated external validation requirements. |
| Secondary Listings | Lowered the financial eligibility for both WVR and non-WVR thresholds (see below ‘Financial eligibility thresholds’) for certain overseas-listed issuers and introduced additional measures to facilitate secondary listings in Hong Kong. |
| Confidential Filing | Extended confidential filing of IPO applications to all new listing applicants, rather than limiting the arrangement to specified categories of issuers. |
| Returned Listing Applications | Enhanced the return mechanism by expanding the information that will be published where a listing application is returned, increasing transparency and encouraging higher-quality submissions. |
| Listing Guidance | Updated, codified and streamlined guidance relating to listing status changes and other listing arrangements to improve clarity and efficiency for applicants. |
Financial eligibility thresholds
Listing pathway | Previous threshold | New threshold |
|---|---|---|
WVR Test A | HK$40 billion market capitalisation | HK$20 billion market capitalisation |
WVR Test B | HK$10 billion market capitalisation + HK$1 billion revenue | HK$6 billion market capitalisation + HK$600 million revenue |
Overseas-listed issuer (non-WVR) | Market capitalization: (A) ≥ HK$3 billion (for a five-year compliant track record on a Qualifying Exchange3 or Recognized Stock Exchange4); or (B) ≥ HK$10 billion (for a two-year compliant track record on a Qualifying Exchange) | Non-WVR: To lower the HK$10 billion market capitalization threshold under test (B) to HK$6 billion. |
The above sheets are summaries of the HKEX’s overall amendments. You may also refer to the detailed disclosure in the original Conclusions.
What does this mean to you?
The reforms make Hong Kong’s listing framework more accessible to a broader range of issuers while retaining its emphasis on disclosure quality and regulatory oversight. Lower financial thresholds may enable more innovative and growth-oriented businesses to qualify for listing, while broader confidential filing provides greater flexibility for companies preparing for an IPO.
For issuers and advisers, the amendments may expand strategic options when planning a Hong Kong listing. However, the changes do not reduce the Exchange’s expectations regarding governance, disclosure and regulatory compliance. Companies should review the revised Listing Rules carefully to determine how the new eligibility criteria and filing procedures may affect future listing plans.
How we can help
That's where Finiti Legal comes in. Finiti is the compliance layer for the world's regulated markets. Give us a filing, and you'll get back: 1) a health check scoring you against the rules your regulator actually enforces, and 2) line-level fixes benchmarked to your peers and the market. In hours, not weeks.
Faster compliance reviews, lower cost, less training overhead, and more confidence that nothing material slips through. Request a complimentary disclosure health check through our website now.